Ornispar Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

L-ornithine-L-aspartate

Indications/Uses

Hyperammonemia due to acute & chronic liver disease eg, liver cirrhosis, fatty liver, hepatitis; treatment of incipient disturbances of consciousness (pre-coma) or neurological complications (hepatic encephalopathy).

Click to view Ornispar detailed prescribing information

Dosage/Direction for Use

May be given up to 4 amp/day. Incipient clouding of consciousness (pre-coma) or clouding of consciousness (coma) Up to 8 amp in 24 hr, depending on the severity of the condition. Venous tolerability Should not exceed 6 amp/500 mL infusion. Max infusion rate: 5 g/hr.

Click to view Ornispar detailed prescribing information

Overdosage

View Ornispar overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity. Severe renal impairment (renal failure); serum creatinine level in excess of 3 mg/100 mL.

Click to view Ornispar detailed prescribing information

Special Precautions

Monitor serum & urinary urea levels. Adjust infusion rate if liver function is substantially impaired. May impair ability to drive or operate machinery. Hepatic impairment. Pregnancy & lactation.

Click to view Ornispar detailed prescribing information

Use In Pregnancy & Lactation

Click to view Ornispar detailed prescribing information

Adverse Reactions

Mild to moderate sensation of heat palpitation, nausea & vomiting.

Click to view Ornispar detailed prescribing information

Storage

View Ornispar storage conditions for details to ensure optimal shelf-life.

Description

View Ornispar description for details of the chemical structure and excipients (inactive components).

Action

View Ornispar mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Cholagogues, Cholelitholytics & Hepatic Protectors

ATC Classification

A05BA - Liver therapy ; Used in liver therapy.

Regulatory Classification

Presentation/Packing

Form

Ornispar soln for infusion 500 mg/mL

Packing/Price

10 mL x 5 × 1's

Ornispar

l-ornithine-l-aspartate

Manufacturer:

PT Novell

Distributor:

Prosweal Healthcare